| 000 | 01456 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516052042.0 | ||
| 264 | 0 | _c20111228 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1424-3997 | ||
| 024 | 7 |
_a10.4414/smw.2011.13240 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFresard, Isabelle | |
| 245 | 0 | 0 |
_aAdverse effects and adherence to treatment of rifampicin 4 months vs isoniazid 6 months for latent tuberculosis: a retrospective analysis. _h[electronic resource] |
| 260 |
_bSwiss medical weekly _c2011 |
||
| 300 |
_aw13240 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 |
_aAntitubercular Agents _xadverse effects |
| 650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xadverse effects |
| 650 | 0 | 4 |
_aLatent Tuberculosis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedication Adherence |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRifampin _xadverse effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBridevaux, Pierre-Olivier | |
| 700 | 1 | _aRochat, Thierry | |
| 700 | 1 | _aJanssens, Jean-Paul | |
| 773 | 0 |
_tSwiss medical weekly _gvol. 141 _gp. w13240 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4414/smw.2011.13240 _zAvailable from publisher's website |
| 999 |
_c21086489 _d21086489 |
||